Sodium/Hydrogen Exchanger 3 (NHE3) Inhibitors

Name
Sodium/Hydrogen Exchanger 3 (NHE3) Inhibitors
Accession Number
DBCAT005681
Description

Agents inhibiting sodium/hydrogen exchanger 3 (NHE3).

Drugs
DrugDrug Description
TenapanorAn NHE3 inhibitor indicated for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic kidney disease,
Drugs & Drug Targets
DrugTargetType
TenapanorSodium/hydrogen exchanger 3target
TenapanorCytochrome P450 3A4enzyme
TenapanorCytochrome P450 3A5enzyme
TenapanorSolute carrier organic anion transporter family member 2B1transporter